Free Trial
→ I'm handing you this one free (From Behind the Markets) (Ad)tc pixel
NASDAQ:SBFMW

Sunshine Biopharma Earnings Date & Estimates

Sunshine Biopharma logo
$0.03 +0.00 (+0.78%)
Closing price 03:59 AM Eastern
Extended Trading
$0.03 0.00 (0.00%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sunshine Biopharma is estimated to report earnings on Tuesday, November 10, 2026, before market opens.

Research:Profile

Upcoming Earnings Announcement

Announcement Date
Time
Before Market Opens
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Sunshine Biopharma

Sunshine Biopharma is expected to post earnings of -$3.40 per share on revenue of $9.60 million.

Consensus Estimates

Consensus EPS
-$3.40
Expected Revenue
$9.60 million

Prepare for the Earnings Call

Sunshine Biopharma Earnings FAQ

Sunshine Biopharma (NASDAQ:SBFMW) is estimated to report earnings on Tuesday, November 10, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Sunshine Biopharma to post earnings of -$3.40 per share for the quarter.

The consensus revenue estimate for Sunshine Biopharma is $9.60 million for the quarter.

Sunshine Biopharma Earnings Headlines

Sunshine Biopharma (SBFMW) Set to Announce Quarterly Earnings on Tuesday
November 9 at 1:56 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31187009
Sunshine Biopharma Launches Generic Ondansetron Tablets In Canada
September 24, 2026  |  rttnews.comhttps://www.rttnews.com/3693703/sunshine-biopharma-launches-generic-ondansetron-tablets-in-canada.aspx
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
November 10 at 1:00 AM  |  Behind the Markets (Ad)
Sunshine Biopharma Expands Oncology Support Portfolio With Generic Zofran Launch In Canada
September 24, 2026  |  rttnews.comhttps://www.rttnews.com/3693735/sunshine-biopharma-expands-oncology-support-portfolio-with-generic-zofran-launch-in-canada.aspx
Sunshine Biopharma Inc.: Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
May 29, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68630289-sunshine-biopharma-inc-sunshine-biopharma-announces-issuance-of-u-s-patent-12-624-066-b2-covering-novel-coronavirus-treatment-technology-200.htm
SBFMW Sunshine Biopharma, Inc. WT EXP 021527
May 19, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/SBFMW
See More Sunshine Biopharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sunshine Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sunshine Biopharma and other key companies, straight to your email.

About Sunshine Biopharma

Sunshine Biopharma (NASDAQ:SBFMW) is a pharmaceutical company focused on generic prescription medicines and the development of new therapies. Its commercial operations are conducted through Nora Pharma, a Canadian subsidiary that markets generic drugs, including products in several therapeutic areas.

The company also pursues drug-development programs, including research into treatments for cancer and other serious diseases. Sunshine Biopharma is based in Canada and is led by Chief Executive Officer Steve Slilaty.

View Sunshine Biopharma Profile
Earnings Tools